文献速递呼吸危重症与机械通气

非侵入性电磁膈神经刺激在危重症患者中的可行性研究

Noninvasive Electromagnetic Phrenic Nerve Stimulation in Critically Ill Patients: A Feasibility Study.
PubMed 文献 · Chest · 2024-02-24

这项非随机对照可行性研究旨在纳入插管36小时内且预期机械通气≥72小时的危重症患者,干预组接受每日两次15分钟双侧经皮非侵入性电磁膈神经刺激(NEPNS),对照组接受标准治疗。因欧盟法规修订要求医疗器械重新审批,研究提前终止,共纳入11例患者(干预组5例,对照组6例)。

要点

  • 双侧经皮NEPNS在ICU危重症患者中可行,寻找最佳刺激位置中位时间仅23秒。
  • NEPNS通气有效性需进一步评估,仅43.0%刺激达到3-6 mL/kg IBW。

核心结论

  • 双侧经皮NEPNS在ICU环境中可行,并具有预防机械通气期间膈肌萎缩的潜在获益。
  • NEPNS的通气有效性仍需进一步评估。

研究设计与样本

  • 可行性非随机对照研究,计划纳入插管36小时内且预期机械通气≥72小时的危重症患者。
  • 干预组接受每日两次15分钟双侧经皮NEPNS,对照组接受标准治疗。
  • 因欧盟法规修订要求医疗器械重新审批,研究提前终止,最终纳入11例患者(干预组5例,对照组6例)。

主要发现

  • 寻找最佳刺激位置的中位时间为23秒(四分位距12-62秒)。
  • 干预组87%患者按方案执行每日两次刺激,包括次日补做则92%患者完成。
  • 仅用刺激时,1701次刺激中732次(43.0%)达到3-6 mL/kg理想体重通气;加用压力支持时,4036次刺激中2511次(62.2%)达到。

临床怎么用

  • 对于预期机械通气≥72小时的危重症患者,可考虑使用双侧经皮NEPNS以预防膈肌萎缩。
  • NEPNS操作可行,但多数刺激需加用压力支持才能达到目标潮气量,通气有效性有限。

局限性

  • 研究因欧盟法规修订要求医疗器械重新审批而提前终止,样本量小(共11例)。
  • 为非随机对照可行性研究,通气有效性需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Electromagnetic stimulation of the phrenic nerve induces diaphragm contractions, but no coils for clinical use have been available. We recently demonstrated the feasibility of ventilation using bilateral transcutaneous noninvasive electromagnetic phrenic nerve stimulation (NEPNS) before surgery in lung-healthy patients with healthy weight in a dose-dependent manner. RESEARCH QUESTION: Is NEPNS feasible in critically ill patients in an ICU setting? STUDY DESIGN AND METHODS: This feasibility nonrandomized controlled study aimed to enroll patients within 36 h of intubation who were expected to remain ventilated for ≥ 72 h. The intervention group received 15-min bilateral transcutaneous NEPNS bid, whereas the control group received standard care. If sufficient, NEPNS was used without pressure support to ventilate the patient; pressure support was added if necessary to ventilate the patient adequately. The primary outcome was feasibility, measured as time to find the optimal stimulation position. Further end points were sessions performed according to the protocol or allowing a next-day catch-up session and tidal volume achieved with stimulation reaching only 3 to 6 mL/kg ideal body weight (IBW). A secondary end point was expiratory diaphragm thickness measured with ultrasound from days 1 to 10 (or extubation). RESULTS: The revised European Union regulation mandated reapproval of medical devices, prematurely halting the study. Eleven patients (five in the intervention group, six in the control group) were enrolled. The median time to find an adequate stimulation position was 23 s (interquartile range, 12-62 s). The intervention bid was executed in 87% of patients, and 92% of patients including a next-day catch-up session. Ventilation with 3 to 6 mL/kg IBW was achieved in 732 of 1,701 stimulations (43.0%) with stimulation only and in 2,511 of 4,036 stimulations (62.2%) with additional pressure support. A decrease in diaphragm thickness was prevented by bilateral NEPNS (P = .034) until day 10. INTERPRETATION: Bilateral transcutaneous NEPNS was feasible in the ICU setting with the potential benefit of preventing diaphragm atrophy during mechanical ventilation. NEPNS ventilation effectiveness needs further assessment. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT05238753; URL: www. CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Panelli A, Grimm AM, Krause S, et al. Noninvasive Electromagnetic Phrenic Nerve Stimulation in Critically Ill Patients: A Feasibility Study. Chest. 2024. PMID: 38403186. doi:10.1016/j.chest.2024.02.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。